Oriola Oyj (HEL:ORIOLA)

Finland flag Finland · Delayed Price · Currency is EUR
1.102
-0.006 (-0.54%)
At close: May 30, 2025
15.51%
Market Cap 198.46M
Revenue (ttm) 1.75B
Net Income (ttm) -23.20M
Shares Out 181.41M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE 17.53
Dividend 0.07 (6.35%)
Ex-Dividend Date Apr 3, 2025
Volume 37,894
Average Volume 63,032
Open 1.108
Previous Close 1.108
Day's Range 1.100 - 1.120
52-Week Range 0.873 - 1.156
Beta 0.42
RSI 50.69
Earnings Date Jul 18, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend... [Read more]

Sector Healthcare
Founded 1907
Employees 934
Stock Exchange Nasdaq Helsinki
Ticker Symbol ORIOLA
Full Company Profile

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial Statements

News

There is no news available yet.